Status Epilepticus Clinical Trial
Official title:
The Role of Cerebral Functional, Structural and Spectral Imaging in the Diagnosis, Management and Prognosis of Status Epilepticus: a Prospective Study in Patients With the Ictal-interictal Continuum
The investigators propose a prospective study of 20 control subjects and 180 consecutive patients with possible non-convulsive status epilepticus (NCSE). The investigators will obtain three functional images of the brain: 1. Fluorodeoxyglucose positron emission tomography (FDG-PET) 2. Perfusion (and structural) magnetic resonance (MR) images 3. Computed tomography (CT) perfusion. Brain hypermetabolism/hyperperfusion is a strong argument to confirm a diagnosis of non-convulsive status epilepticus. The aim is to determine which of the three functional imaging techniques is the most sensitive and easy to obtain in the detection of hypermetabolism/hyperperfusion. The investigators will determine which EEG patterns are associated with hypermetabolism/perfusion. The investigators will further study and describe the management with antiseizure medication and outcome of the group with possible non-convulsive status epilepticus WITH hypermetabolism/hyperperfusion versus the group with possible non-convulsive status epilpticus WITHOUT hypermetabolism/hyperperfusion. The investigators will make recommendations for an imaging protocol in possible NCSE for widespread use. The aim is to offer guidelines to incorporate imaging in the diagnosis, management and prognosis of NCSE in patients with the ictal-interictal continuum.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03883516 -
Improving Emergency Management of Status Epilepticus
|
N/A | |
| Recruiting |
NCT03378687 -
A Clinical Study of Children With Status Epilepticus in China
|
N/A | |
| Recruiting |
NCT00362141 -
Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
|
Phase 2 | |
| Recruiting |
NCT05140265 -
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
|
||
| Active, not recruiting |
NCT04391569 -
Randomized Therapy In Status Epilepticus
|
Phase 3 | |
| Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 | |
| Recruiting |
NCT05491590 -
Patient-reported Outcome After Status Epilepticus
|
||
| Recruiting |
NCT04421846 -
Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
|
N/A | |
| Completed |
NCT02958605 -
Smartphone Apps for Pediatric Resuscitation
|
N/A | |
| Completed |
NCT02239380 -
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
|
Phase 3 | |
| Completed |
NCT01796574 -
Ketogenic Diet for Refractory Status Epilepticus
|
N/A | |
| Completed |
NCT02381977 -
Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment
|
N/A | |
| Completed |
NCT00004297 -
Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus
|
Phase 3 | |
| Completed |
NCT03905798 -
LORA-PITA IV General Investigation
|
||
| Recruiting |
NCT05591508 -
Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus
|
N/A | |
| Completed |
NCT00735527 -
Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children
|
Phase 3 | |
| Terminated |
NCT00265616 -
Treatment of Refractory Status Epilepticus
|
Phase 3 | |
| Recruiting |
NCT06401707 -
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
|
Phase 2 | |
| Enrolling by invitation |
NCT06403150 -
The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus
|
Phase 4 | |
| Recruiting |
NCT05246566 -
Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana
|